DAXOR CORP

Regulatory Filings • Jun 30, 2021

8-K 1 form8-k.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 24, 2021

Daxor Corporation

Field: Rule-Page

Field: /Rule-Page

(Exact name of registrant as specified in its charter)

| New
York | 811-22684 | 13-2682108 |
| --- | --- | --- |
| (State
or other jurisdiction | (Commission | (IRS
Employer |
| of
incorporation) | File
Number) | Identification
No.) |

| 109
Meco Lane, Oak Ridge, TN | 37830 |
| --- | --- |
| (Address
of principal executive offices) | (Zip
Code) |

212-330-8500

Field: Rule-Page

Field: /Rule-Page

Registrant’s telephone number, including area code

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

| [ ] | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| --- | --- |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title
of each class | Trading
Symbol(s) | Name
of each exchange on which registered |
| --- | --- | --- |
| Common
Stock $0.01 par value | DXR | NYSE
AMERICAN |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 5.07 Submission of Matters to a Vote of Security Holders

The Company’s Annual Meeting was held June 24, 2021. At the Annual Meeting, the following directors were elected for terms expiring at the annual meeting of shareholders to be held in 2022 by the votes indicated:

James Lombard	2,964,273	12,584	387,427
Henry D. Cremisi, MD	2,966,805	10,052	387,427
Edward Feuer	2,967,285	9,572	387,427
Joy Goudie, Esq.	2,966,805	10,052	387,427
Michael Feldschuh	2,898,106	78,751	387,427
Jonathan Feldschuh	2,898,106	78,751	387,427

The following reflects the voting results for matters other than the election of directors brought for vote at the Annual Meeting:

Ratification of WithumSmith+Brown, PC as Daxor Corporation’s independent registered public accounting firm	3,354,996	6,033	3,255	0

Field: Page; Sequence: 2; Options: NewSection; Value: 2

2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

| | DAXOR
CORPORATION | |
| --- | --- | --- |
| | (Registrant) | |
| Date:
June 30, 2021 | By: | /s/
Robert J. Michel |
| | Name: | Robert
J. Michel |
| | Title: | Chief
Financial Officer |

Field: Page; Sequence: 3; Options: Last

3

Field: /Page